Company intelligence / Profile preview

Fresenius (for Prometheus)

Bad Homburg v. d. Höhe, Hesse, Germany

Ownership: Private
Employees: ~176000
Development stage: Other

Overview

The Prometheus system is a clinically available device for extracorporeal liver support therapy. Published clinical results show removal of albumin-bound and water-soluble toxins and a stabilizing effect on hemodynamics in patients with liver failure, though effect on mortality remains debated.[4][6]

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Prometheus Laboratories (for therapeutic drug monitoring collaboration in IBD and biosimilars)[5]

Beyond the preview

Go deeper on Fresenius (for Prometheus).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fresenius (for Prometheus).

Explore the full profile